2024-11-20 13:16:39
CStone announces China NMPA acceptance of IND application for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody-based molecule, marking further expansion of its Pipeline 2.0 strategy
Corporate/ 2023-07-23
CStone announces China NMPA acceptance o...

SUZHOU,China,July 7,2021--CStone Pharmaceuticals ("CStone",HKEX: 2616),a leading biopharmaceutical company focused on the research...

Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA
Health/ 2023-07-22
Biocytogen/Eucure Biopharma's CTLA-...

BOSTONandBEIJING,July 7,2021-- Eucure Biopharma,a wholly owned subsidiary ofBiocytogendedicated to developing antibody drugs with independen...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release